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Introduction
Glycogen storage disease type II (Pompe disease or acid
maltase deficiency) is an autosomal recessive metabolic
disorder caused by a deficiency of the lysosomal enzyme
acid alpha-glucosidase. Accumulation of glycogen in the
lysosomes damages muscle cells throughout the body.
In response to that damage, we hypothesized that cyto-
kines (a family of proteins that mediate innate and adap-
tive immunity) would be elevated. We investigated 30
(15 female, 15 male) Pompe patients before ERT start
and 1 year after ERT and used high-resolution ELISA.
Results
Before ERT start in 20 patients (12f, 8m) we saw ele-
vated TNFy and Interleukin-2. After treatment more
than 50% TNFy was normalized. But after treatment
some cytokines were elevated. We don’t see any correla-
tion between antibody levels against ERT in these
patients.
Conclusion
Our results showed that some patients had elevated
cytokines and monocytes. Our hypothesis is that also
immunological factors play also a role in disease, caus-
ing the development of pain in Pompe disease. Now we
are looking for correlations between pain and cytokines
levels, and results will follow.
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